Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

DHR – Danaher Corporation

Danaher Corporation
DHR
$181.77
Name : Danaher Corporation
Sector : Healthcare
Industry: Diagnostics & Research
Mark. Cap: $130,047,344,640.00
EPSttm : 5.28
finviz dynamic chart for DHR
Danaher Corporation
$181.77
8.15%
$16.13

Float Short %

1.2

Margin Of Safety %

2

Put/Call OI Ratio

0.54

EPS Next Q Diff

-0.38

EPS Last/This Y

2.33

EPS This/Next Y

0.92

Price

197.72

Target Price

264.13

Analyst Recom

1.43

Performance Q

-13.79

Relative Volume

1.14

Beta

0.8

Ticker: DHR




22 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-03-05DHR210.640.510.44115604
2025-03-06DHR214.840.521.50116798
2025-03-07DHR211.980.531.45117006
2025-03-10DHR205.190.573.05113050
2025-03-11DHR205.650.570.76113545
2025-03-12DHR204.950.550.46115014
2025-03-13DHR204.130.542.32118835
2025-03-14DHR210.720.523.04122623
2025-03-17DHR212.560.551.34120335
2025-03-18DHR212.790.550.48120938
2025-03-19DHR210.240.530.57122971
2025-03-20DHR210.240.542.22123378
2025-03-21DHR211.360.511.69126740
2025-03-24DHR212.310.500.6891293
2025-03-25DHR212.520.490.7293677
2025-03-26DHR210.410.480.4794684
2025-03-27DHR210.10.481.2097625
2025-03-28DHR205.80.491.32102403
2025-03-31DHR204.970.511.49101530
2025-04-01DHR200.360.511.94105629
2025-04-02DHR205.150.550.93109898
2025-04-03DHR197.750.542.57110754
DateSymbolLastP/C OIP/C VolTotal OI
22 items Current Page1 of 1




22 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-03-05DHR210.60-14.81159.97.65
2025-03-06DHR214.92-14.81149.07.65
2025-03-07DHR212.01-14.8966.07.65
2025-03-10DHR205.23-14.8861.97.65
2025-03-11DHR205.63-14.81047.37.65
2025-03-12DHR205.01-14.81021.07.65
2025-03-13DHR204.16-14.81015.77.65
2025-03-14DHR210.74-14.81212.97.65
2025-03-17DHR212.60-14.81084.67.65
2025-03-18DHR212.80-14.81041.97.65
2025-03-19DHR210.26-14.8972.57.65
2025-03-20DHR210.25-14.81035.57.65
2025-03-21DHR211.44-14.81067.57.65
2025-03-24DHR212.80-14.81073.77.65
2025-03-25DHR212.40-14.81026.67.66
2025-03-26DHR210.41-14.8986.07.66
2025-03-27DHR210.11-14.81029.17.66
2025-03-28DHR205.85-14.8935.17.66
2025-03-31DHR204.94-14.81021.17.66
2025-04-01DHR200.39-14.8923.37.66
2025-04-02DHR205.16-14.81173.67.66
2025-04-03DHR197.72-14.8848.77.66
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
22 items Current Page1 of 1




22 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-03-05DHR-0.14-0.210.91
2025-03-06DHR-0.14-0.210.91
2025-03-07DHR-0.14-0.210.91
2025-03-10DHR-0.140.180.91
2025-03-11DHR-0.140.180.91
2025-03-12DHR-0.140.181.19
2025-03-13DHR-0.140.181.19
2025-03-14DHR-0.140.181.19
2025-03-17DHR-0.140.181.19
2025-03-18DHR-0.060.181.26
2025-03-19DHR-0.060.181.26
2025-03-20DHR-0.060.181.26
2025-03-21DHR-0.060.181.26
2025-03-24DHR-0.060.181.26
2025-03-25DHR-0.060.181.26
2025-03-26DHR-0.060.181.20
2025-03-27DHR-0.060.181.20
2025-03-28DHR-0.060.181.20
2025-03-31DHR-0.060.181.20
2025-04-01DHR-0.060.181.20
2025-04-02DHR-0.060.181.20
2025-04-03DHR-0.060.181.20
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
22 items Current Page1 of 1

Last Quarter Act. EPS

2.14

Avg. EPS Est. Current Quarter

1.64

Avg. EPS Est. Next Quarter

1.76

Insider Transactions

-0.06

Institutional Transactions

0.18

Beta

0.8

Average Sales Estimate Current Quarter

5576

Average Sales Estimate Next Quarter

5808

Fair Value

202.07

Quality Score

88

Growth Score

77

Sentiment Score

14

Actual DrawDown %

33.2

Max Drawdown 5-Year %

-36.6

Target Price

264.13

P/E

37.43

Forward P/E

23.03

PEG

4.46

P/S

5.93

P/B

2.87

P/Free Cash Flow

26.73

EPS

5.29

Average EPS Est. Cur. Y​

7.66

EPS Next Y. (Est.)

8.58

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

16.33

Relative Volume

1.14

Return on Equity vs Sector %

-11.9

Return on Equity vs Industry %

-2.9

EPS 1 7Days Diff

EPS 1 30Days Diff

0.01

EBIT Estimation

848.7
Danaher Corporation
Sector: Healthcare
Industry: Diagnostics & Research
Employees: 61000
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment offers bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions. Its Life Sciences segment provides mass spectrometers; bioanalytical measurement systems; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies, and particle counting and characterization; genome sample preparation; microscopes; protein consumables; filtration products; and genomic medicines, such as custom nucleic acid products, and plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, GENEDATA, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX brands. The Diagnostics segment offers clinical instruments, consumables, software, and services in the areas of clinical chemistry, immunoassay, hematology, and microbiology for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District Of Columbia.
stock quote shares DHR – Danaher Corporation Stock Price stock today
news today DHR – Danaher Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch DHR – Danaher Corporation yahoo finance google finance
stock history DHR – Danaher Corporation invest stock market
stock prices DHR premarket after hours
ticker DHR fair value insiders trading